LONDON, June 25, 2026
Evaluate, a Norstella company and a leading provider of pharmaceutical market intelligence, has been recognized for excellence in artificial intelligence after its Ask Ella platform was named “Enterprise AI Search Solution of the Year” in the 9th Annual AI Breakthrough Awards. The prestigious award recognizes innovative AI technologies transforming industries worldwide and highlights Ask Ella’s ability to deliver rapid, data-driven insights for life sciences organizations. Integrated into the Evaluate Pharma platform, Ask Ella leverages advanced artificial intelligence to interpret complex pharmaceutical data, answer sophisticated business questions, and provide structured, traceable insights within seconds. The recognition reinforces Evaluate’s growing leadership in applying AI to pharmaceutical market intelligence while supporting faster strategic decision-making across drug development, competitive intelligence, forecasting, portfolio management, and commercial planning. As artificial intelligence continues reshaping the pharmaceutical industry, the award highlights the increasing role of intelligent automation in accelerating innovation throughout the global biopharmaceutical ecosystem.
Ask Ella Transforms Pharmaceutical Intelligence Through AI
Unlike conventional enterprise search tools, Ask Ella combines artificial intelligence, advanced reasoning, and proprietary pharmaceutical datasets to deliver highly contextual, evidence-based responses tailored to life sciences professionals. Rather than simply retrieving documents, the platform automatically breaks down complex scientific and commercial questions into structured analytical workflows before synthesizing large volumes of pharmaceutical market data into concise, actionable insights. The AI-powered solution enables users to evaluate market dynamics, competitor activity, portfolio performance, pipeline opportunities, and commercial forecasts without interrupting existing workflows. By significantly reducing the time required to analyze complex industry information, Ask Ella enables pharmaceutical organizations to focus on higher-value strategic decisions while maintaining the accuracy, traceability, and reliability demanded throughout the life sciences industry.
Award Recognizes Growing AI Innovation Across Life Sciences
The AI Breakthrough Awards represent one of the technology industry’s leading recognition programs for artificial intelligence innovation, attracting thousands of nominations from more than 20 countries across categories including Generative AI, Agentic AI, Machine Learning, Robotics, Computer Vision, Natural Language Processing, and enterprise AI applications. Evaluate’s recognition reflects the increasing adoption of AI technologies throughout pharmaceutical research and commercialization, where intelligent analytics are helping organizations accelerate forecasting, clinical development, regulatory planning, market access strategies, and patient engagement.
Advertisement
The award also recognizes Norstella’s broader AI strategy, which already includes more than two dozen AI agents supporting pharmaceutical decision-making across multiple stages of the drug development lifecycle. Company leadership indicated that the next phase of innovation will include an agentic AI platform capable of autonomously synthesizing, interpreting, and acting upon highly complex biopharmaceutical datasets.
AI-Powered Decision Intelligence Supports Future Drug Development
As pharmaceutical organizations face increasingly complex scientific, regulatory, and commercial environments, AI-powered decision support platforms are becoming critical tools for accelerating innovation while improving operational efficiency. Evaluate’s continued investment in artificial intelligence reflects a broader industry trend toward integrating predictive analytics, intelligent search, data automation, and machine reasoning into pharmaceutical workflows. By transforming large volumes of structured and unstructured market intelligence into actionable business insights, Ask Ella enables organizations to make faster, more informed decisions across drug discovery, clinical trial planning, competitive intelligence, commercialization, and portfolio strategy.
The latest industry recognition further strengthens Evaluate’s position as a leader in pharmaceutical market intelligence while demonstrating how artificial intelligence is reshaping the future of life sciences decision-making. As AI adoption accelerates across the healthcare sector, platforms such as Ask Ella are expected to play an increasingly important role in helping pharmaceutical companies reduce development timelines, improve strategic planning, and ultimately accelerate the delivery of innovative therapies to patients worldwide.
Source: Evaluate press release
